<VariationArchive VariationID="422357" VariationName="NM_000642.3(AGL):c.4506_4510del (p.Glu1502fs)" VariationType="Deletion" Accession="VCV000422357" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="405279" VariationID="422357">
      <GeneList>
        <Gene Symbol="AGL" FullName="amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" GeneID="178" HGNC_ID="HGNC:321" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99849258" stop="99924023" display_start="99849258" display_stop="99924023" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100315639" stop="100389578" display_start="100315639" display_stop="100389578" Strand="+" />
          </Location>
          <OMIM>610860</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000642.3(AGL):c.4506_4510del (p.Glu1502fs)</Name>
      <CanonicalSPDI>NC_000001.11:99921555:GAACTGA:GA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99921556" stop="99921560" display_start="99921556" display_stop="99921560" variantLength="5" positionVCF="99921555" referenceAlleleVCF="AGAACT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100387112" stop="100387116" display_start="100387112" display_stop="100387116" variantLength="5" positionVCF="100387111" referenceAlleleVCF="AGAACT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E1486fs</ProteinChange>
      <ProteinChange>E1502fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000644.3" sequenceAccession="NM_000644" sequenceVersion="3" change="c.4506_4510delACTGA">
            <Expression>NM_000644.3:c.4506_4510delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000635.2" sequenceAccession="NP_000635" sequenceVersion="2" change="p.Glu1502Aspfs">
            <Expression>NP_000635.2:p.Glu1502Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000646.3" sequenceAccession="NM_000646" sequenceVersion="3" change="c.4458_4462delACTGA">
            <Expression>NM_000646.3:c.4458_4462delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000637.2" sequenceAccession="NP_000637" sequenceVersion="2" change="p.Glu1486Aspfs">
            <Expression>NP_000637.2:p.Glu1486Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425325.1" sequenceAccession="NM_001425325" sequenceVersion="1" change="c.4506_4510delACTGA">
            <Expression>NM_001425325.1:c.4506_4510delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412254.1" sequenceAccession="NP_001412254" sequenceVersion="1" change="p.Glu1502Aspfs">
            <Expression>NP_001412254.1:p.Glu1502Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425326.1" sequenceAccession="NM_001425326" sequenceVersion="1" change="c.4485_4489delACTGA">
            <Expression>NM_001425326.1:c.4485_4489delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412255.1" sequenceAccession="NP_001412255" sequenceVersion="1" change="p.Glu1495Aspfs">
            <Expression>NP_001412255.1:p.Glu1495Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425327.1" sequenceAccession="NM_001425327" sequenceVersion="1" change="c.4305_4309delACTGA">
            <Expression>NM_001425327.1:c.4305_4309delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412256.1" sequenceAccession="NP_001412256" sequenceVersion="1" change="p.Glu1435Aspfs">
            <Expression>NP_001412256.1:p.Glu1435Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425328.1" sequenceAccession="NM_001425328" sequenceVersion="1" change="c.4302_4306delACTGA">
            <Expression>NM_001425328.1:c.4302_4306delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412257.1" sequenceAccession="NP_001412257" sequenceVersion="1" change="p.Glu1434Aspfs">
            <Expression>NP_001412257.1:p.Glu1434Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425329.1" sequenceAccession="NM_001425329" sequenceVersion="1" change="c.4167_4171delACTGA">
            <Expression>NM_001425329.1:c.4167_4171delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412258.1" sequenceAccession="NP_001412258" sequenceVersion="1" change="p.Glu1389Aspfs">
            <Expression>NP_001412258.1:p.Glu1389Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425332.1" sequenceAccession="NM_001425332" sequenceVersion="1" change="c.4128_4132delACTGA">
            <Expression>NM_001425332.1:c.4128_4132delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412261.1" sequenceAccession="NP_001412261" sequenceVersion="1" change="p.Glu1376Aspfs">
            <Expression>NP_001412261.1:p.Glu1376Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000642.3" sequenceAccession="NM_000642" sequenceVersion="3" change="c.4506_4510del" MANESelect="true">
            <Expression>NM_000642.3:c.4506_4510del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000633.2" sequenceAccession="NP_000633" sequenceVersion="2" change="p.Glu1502fs">
            <Expression>NP_000633.2:p.Glu1502fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000643.3" sequenceAccession="NM_000643" sequenceVersion="3" change="c.4506_4510delACTGA">
            <Expression>NM_000643.3:c.4506_4510delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000634.2" sequenceAccession="NP_000634" sequenceVersion="2" change="p.Glu1502Aspfs">
            <Expression>NP_000634.2:p.Glu1502Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.100387114_100387118del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.100387114_100387118del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.99921558_99921562del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.99921558_99921562del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012865.1" sequenceAccession="NG_012865" sequenceVersion="1" change="g.76475_76479del">
            <Expression>NG_012865.1:g.76475_76479del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000028.3" sequenceAccession="NM_000028" sequenceVersion="3" change="c.4506_4510delACTGA">
            <Expression>NM_000028.3:c.4506_4510delACTGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000019.2" sequenceAccession="NP_000019" sequenceVersion="2" change="p.Glu1502Aspfs">
            <Expression>NP_000019.2:p.Glu1502Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16617221" DB="ClinGen" />
        <XRef Type="rs" ID="1064795728" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000642.3(AGL):c.4506_4510del (p.Glu1502fs) AND not provided" Accession="RCV000482459" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-10-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000642.3(AGL):c.4506_4510del (p.Glu1502fs) AND Glycogen storage disease type III" Accession="RCV003633509" Version="1">
        <ClassifiedConditionList TraitSetID="6278">
          <ClassifiedCondition DB="MedGen" ID="C0017922">Glycogen storage disease type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20071996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20490926</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8990006</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6278" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2236" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Forbes disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cori disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limit dextrinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylo-1,6-glucosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen debrancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease type III</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+3/3123" DB="Genetic Alliance" />
                <XRef ID="66937008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD3</ElementValue>
                <XRef Type="MIM" ID="232400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most common subtype, present in about 85% of affected individuals; it manifests with liver and muscle involvement. GSD IIIb, with liver involvement only, comprises about 15% of all affected individuals. In infancy and early childhood, liver involvement presents as hepatomegaly and failure to thrive, with fasting ketotic hypoglycemia, hyperlipidemia, and elevated hepatic transaminases. In adolescence and adulthood, liver disease becomes less prominent. Most individuals develop cardiac involvement with cardiac hypertrophy and/or cardiomyopathy. Skeletal myopathy manifesting as weakness may be evident in childhood and slowly progresses, typically becoming prominent in the third to fourth decade. The overall prognosis is favorable but cannot be predicted on an individual basis. Long-term complications such as muscular and cardiac symptoms as well as liver fibrosis/cirrhosis and hepatocellular carcinoma may have a severe impact on prognosis and quality of life. To date, it is unknown if long-term complications can be alleviated and/or avoided by dietary interventions.</Attribute>
                <XRef ID="NBK26372" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9442" />
                <XRef ID="9442" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301788</ID>
                <ID Source="BookShelf">NBK26372</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2010">
                <ID Source="PubMed">20631546</ID>
              </Citation>
              <XRef ID="366" DB="Orphanet" />
              <XRef ID="C0017922" DB="MedGen" />
              <XRef ID="MONDO:0009291" DB="MONDO" />
              <XRef Type="MIM" ID="232400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1106915" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:1292662|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000571808" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.4506_4510delACTGA variant in the AGL gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes a frameshift starting with codon Glutamic Acid 1502, changes this amino acid to an Aspartic Acid residue, and creates a premature Stop codon at position 3 of the new reading frame, denoted p.Glu1502AspfsX3. This variant is predicted to cause loss of normal protein function through protein truncation, as the last 31 amino acids of the protein are replaced with 2 incorrect amino acids. The c.4506_4510delACTGA variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.4506_4510delACTGA variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4506_4510delACTGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8197269" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="17841280|MedGen:C0017922" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004408981" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8990006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20071996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20490926</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430490</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu1502Aspfs*3) in the AGL gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 31 amino acid(s) of the AGL protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the AGL protein in which other variant(s) (p.Tyr1510*) have been determined to be pathogenic (PMID: 8990006, 20071996, 20490926, 23430490). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 422357). This variant has not been reported in the literature in individuals affected with AGL-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.100387112_100387116del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017922" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8197269" TraitType="Disease" MappingType="XRef" MappingValue="C0017922" MappingRef="MedGen">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1106915" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

